Skip to content
Acceleron Pharma

Investors/Media

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Apr 25, 2007
CAMBRIDGE, MA – April 25, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced the appointment of James Desiderio, Ph.D. as Vice President, Program Management.. “The Acceleron pro...
Apr 1, 2007
Link to article
Mar 29, 2007
CAMBRIDGE, MA – March 29, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced the appointment of Robert Steininger as Senior Vice President, Manufacturing. “Acceleron is rapidly advancing and ...
Mar 7, 2007
CAMBRIDGE, MA – March 7, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that Steven Ertel, Vice President Business Development, will provide a corporate presentation at the Cowen and Company 27th Annual Health Care Conference on Thursday March 15, 2007 at 9:30...
Nov 3, 2006
CAMBRIDGE, MA – November 3, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company developing regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a corporate presentation at the Rodman & Renshaw 8th Annual Healthcare Conference on Monday, November 6, 2006 at 4:55 p.m. (EST)....
Oct 30, 2006
CAMBRIDGE, MA – October 30, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a corporate presentation at the Massachusetts Biotechnology Council’s MASS Opportunities Conference on Thur...
Sep 18, 2006
CAMBRIDGE, MA – September 18, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, presented preclinical data highlighting the anabolic bone activity of ACE-011, the company’s lead drug candidate currently in a phase 1 clinical trial, at the Annual Meeting of the A...
Sep 12, 2006
CAMBRIDGE, MA – September 12, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, announced that it will present preclinical data highlighting the anabolic bone activity of ACE-011, the company’s lead drug candidate and a novel treatment for bone loss, at the Annu...
Aug 21, 2006
Red Herring, August 21, 2006
Aug 3, 2006
BioWorld Today, August 3, 2006
Aug 2, 2006
CAMBRIDGE, MA – August 2, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, today announced that it secured a $30 million Series B financing. OrbiMed Advisors, the sole new investor, led the round with participation by all existing institutional investors including Ad...
Jul 17, 2006
BioCentury, July 17, 2006
Jun 21, 2006
CAMBRIDGE, MA – June 21, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics , announced that it has initiated a Phase 1 clinical trial of ACE-011, a novel treatment for bone loss disease, particularly osteoporosis. ACE-011 is the first regenerative therapeutic to enter ...
May 16, 2006
CAMBRIDGE, MA – May 16, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company focused on developing and commercializing therapeutics based on its novel tissue growth factor platform, today announced the appointment of Matthew L. Sherman, M.D. as Senior Vice President and Chief Medical Officer. “Acceleron has built ...
Jun 14, 2004
CAMBRIDGE, MA – June 14, 2004 – Acceleron Pharma announced today the appointment of Glenn Batchelder as president and CEO and a member of the board of directors. Batchelder has been a senior executive at Millennium Pharmaceuticals for the past five years. Acceleron also announced that biopharmaceutical veteran Richard Pops, CEO ...
= add release to Briefcase